Danaher Corp
Close on Oct 30, 2026Market cap $163.25BP/E 41.2Yield –
Danaher Beckman Coulter (Diagnostics & Life Sciences) by Year
Beckman Coulter (Diagnostics & Life Sciences) — MAUDE Adverse Event Reports
Danaher Beckman Coulter (Diagnostics & Life Sciences): 745 in FY2025, up 6.1% from a year earlier.
Where the FY2025 figure comes from
Source: U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Reported in U.S. FDA openFDA MAUDE Adverse Event API.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Danaher Beckman Coulter (Diagnostics & Life Sciences), annual FY2015–FY2025 [Data set]. Compiled from Danaher SEC filings and investor materials. https://stockdatahq.com/stocks/dhr/kpis/ext-fda-maude-beckman-coulter
See every metric in the Danaher KPI table. Data updated Nov 2, 2026.